As Cellura continues to develop its activities at the intersection of cell culture, biotechnology and biopharmaceutical applications, CPHI Milan represents an opportunity to engage with an international ecosystem involved in pharmaceutical development, bioproduction and manufacturing.
For Cellura, the objective is not only to follow emerging industry trends, but also to better understand how the requirements surrounding advanced biological production and cell-based processes are evolving, and where new approaches to cell culture can contribute.
Connecting Cell Culture with Biopharmaceutical Development
Moving from biological research toward pharmaceutical and industrial applications introduces new expectations for cell culture processes.
Beyond biological performance, developers increasingly need to consider reproducibility, process control, scalability and compatibility with more standardized production environments.
These challenges are closely connected to Cellura’s perspective on the evolution of cell culture. CPHI Milan will provide an opportunity to exchange with pharmaceutical and biotechnology teams facing these questions and to better understand the constraints encountered when biological processes progress toward larger-scale applications.
Exploring New Industrial Perspectives
Cellura’s presence at CPHI Milan is also an opportunity to broaden its interactions beyond the research environment and explore how its technologies could fit within biopharmaceutical development and manufacturing workflows.
Discussions with pharmaceutical companies, biotechnology teams, technology providers and industrial partners will help identify new needs around cell expansion, process development, standardization and scale-up.
These exchanges are particularly valuable for Cellura as it continues to explore applications involving sensitive cellular systems and seeks to build stronger connections between advanced cell culture and industrial bioprocessing requirements.
Building Future Collaborations
CPHI Milan will also provide an important setting for identifying potential scientific, technological and industrial collaborations.
For Cellura, establishing these connections is essential to understanding future applications, evaluating new use cases and continuing to develop culture approaches that respond to the practical needs of biotechnology and pharmaceutical teams.
By attending CPHI Milan 2026, Cellura aims to strengthen its presence within the international pharmaceutical ecosystem while continuing to explore how controlled, reproducible and scalable cell culture can support the evolution of biological production.
We look forward to meeting the community in Milan from October 6 to 8, 2026.
About the Event
More information about CPHI Milan 2026 is available on the official website: https://www.cphi.com/europe/
For further information or to arrange a meeting with the Cellura team during the event:
Email: contact@cellura.io
